Authenticx
Authenticx Announces $20M in Series B Funding to Enhance the Customer Journey
Authenticx announced $20M in a Series B funding led by Blue Heron Capital with participation from Beringea, Indiana Next Level Fund/50 South Capital Advisors, High Alpha, Mutual Capital Partners, Signal Peak Ventures, Allos Ventures, Elevate Ventures and M25.
The investment comes after a significant year of growth for Authenticx, which saw a 2.5x increase in ARR in 2022 and 64 new employees since July 2021, many of whom joined product innovation and sales departments. Additionally, Authenticx’s customer base doubled over the last year, with its client portfolio now including five of the top 10 leading global pharmaceutical companies.
Authenticx plans to use this capital infusion to further increase customer-centricity in healthcare by:
Innovating in machine learning and product engineering
Fueling sales and marketing efforts
Continuing to expand the business
Authenticx is the new standard for humanizing conversational intelligence in healthcare by analyzing millions of customer interactions (like voice, chat, or emails) to surface immersive and intelligent insights at scale. Authenticx was founded to aggregate, analyze and activate customer interaction data to surface transformational opportunities in healthcare. Using existing data that’s likely being stored and ignored in your organization, Authenticx reveals hidden barriers, motivators, and strategies so healthcare organizations can make confident, data-backed decisions.
